AstraZeneca Invests $2B in Maryland, Creating 2600 Jobs
Update: 2025-11-21
Description
AstraZeneca, a global pharmaceutical giant, is investing $2 billion in Maryland to expand its manufacturing operations, part of a $50 billion U.S. growth plan by 2030. The company will expand its Frederick facility and build a new one in Gaithersburg for clinical trial drugs, creating 2,600 jobs. This move aligns with Trumps call for increased domestic production and AstraZenecas strategic initiatives.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
